According to the recent study the immunofluorescence assay market is projected to reach an estimated $4.0 billion by 2028 from $2.9 billion in 2023, at a CAGR of 5.9% from 2023 to 2028. Growth in this market is primarily driven by increasing incidences of chronic diseases, growing government investments in healthcare, and rising R&D activities for technological advancements. A more than...